ICDcodes.org
FY2027

E72.548Other secondary hyperoxaluria

Billable

Is E72.548 billable?

Yes — E72.548 is billable for FY2027. E72.548 is a valid, billable ICD-10-CM code at the highest level of specificity in its branch. E72.548 may be submitted for encounters from October 1, 2026 through September 30, 2027.

E72.548 at a glance

CodeE72.548
DescriptionOther secondary hyperoxaluria
BillableYes
Code setICD-10-CM FY2027
Valid for encountersOctober 1, 2026 – September 30, 2027

Which MS-DRGs does E72.548 group to?

E72.548 sits in MDC 11 and helps define the logic of 2 MS-DRGs (version 44, FY2027). Which one a stay actually groups to also depends on procedures and secondary diagnoses.

  • 695Kidney and Urinary Tract Signs and Symptoms with MCCmedical
  • 696Kidney and Urinary Tract Signs and Symptoms without MCCmedical

How is E72.548 listed in the Alphabetic Index?

These are the routes through the Alphabetic Index that lead to E72.548. They show the wording a clinician may have documented, which often differs from the Tabular description.

  • Disorderglycine metabolismhyperoxaluriasecondaryspecified type NEC (of)

Excludes1 — never code together — inherited from Chapter 4

The conditions below can never be reported together with E72.548 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.

  • transitory endocrine and metabolic disorders specific to newborn (P70-P74)

Excludes1 — never code together — inherited from E70-E88

The conditions below can never be reported together with E72.548 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.

  • androgen insensitivity syndrome (E34.5-)
  • congenital adrenal hyperplasia (E25.0)
  • hemolytic anemias attributable to enzyme disorders (D55.-)
  • Marfan syndrome (Q87.4-)
  • 5-alpha-reductase deficiency (E29.1)

Excludes1 — never code together — inherited from E72

The conditions below can never be reported together with E72.548 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.

  • disorders of:
  • aromatic amino-acid metabolism (E70.-)
  • branched-chain amino-acid metabolism (E71.0-E71.2)
  • fatty-acid metabolism (E71.3)
  • purine and pyrimidine metabolism (E79.-)
  • gout (M1A.-, M10.-)

Excludes1 — never code together — inherited from E72.54

The conditions below can never be reported together with E72.548 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.

Excludes2 — not included here — inherited from E70-E88

The conditions below are not part of E72.548, but a patient may have both at the same time. When documentation supports it, E72.548 and the excluded code may both be reported.

  • Ehlers-Danlos syndromes (Q79.6-)

How long has E72.548 existed?

E72.548 first appears in FY2026.

Derived from the official order files for FY2016–FY2026. FY2017 and FY2020 publish no order file, so those years are not covered.

What other codes are in the E72.54 family? (3)